Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sucrosomial Iron vs Ferric Maltol in Iron Deficient Women
2025-522004-24-00Phase 4Authorised
- Sponsor
- PharmaNutra
- Start
- Oct 2025
- Modality
- Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sucrosomial iron in iron deficiency anemia (IDA) (2 arms), sponsored by PharmaNutra. Planned start Oct 2025; status: authorised.
02
Drugs
sucrosomial iron
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2025-522004-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522004-24-00.